Human Genome Sciences, Inc. (NASDAQ: HGSI) will present at the DB 2009 Biotech Boston Confab. The company's senior management will present a corporate overview. The conference is being held in Boston, Ma, at the Four Seasons Hotel Boston. They are scheduled to present on December 15, 2009 at 1:05 pm (EST). The company's presentation will be available through their website. A replay will also remain available for several days after the event.
MicroCap Insider is a web-based financial portal that publishes a free penny stock newsletter providing stock alerts on companies positioned to deliver high-yield gains to investors. Sign Up for our Free Stock Newsletter
About Human Genome Sciences
The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax and cancer.
Investors interested in receiving small cap stock alerts through the penny stock newsletter published by MicroCap Insider can sign up for free by visiting our website
About Us
MicroCap Insider is a leading penny stock web site with extensive experience in the OTC market, providing top stock picks, investing tips and exclusive research on small cap stocks on the verge of producing large financial gains.
Please click here to read the full disclaimer
